Veradigm | MDRX - Current Assets


Veradigm reported $679.65M in Current Assets for its fiscal quarter ending in December of 2022.





Current Assets Change Date
Alcidion AUD 28.52M 4.83M Dec/2025
Ambu A/S DKK 3.1B 26M Sep/2026
Amplifon EUR 442.25M 320.71M Jun/2026
Cardinal Health USD 40.99B 2.24B Sep/2026
Centene USD 45.46B 1.22B Sep/2026
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Cigna USD 47.23B 241M Sep/2026
Coloplast 10.3B 155M Dec/2025
Convatec Group USD 793.3M 70.6M Dec/2024
CVS Health USD 79.39B 4.05B Sep/2026
Diasorin EUR 752.2M 7.42M Jun/2026
Elevance Health USD 68.52B 1.34B Sep/2026
General Electric Aerospace USD 41.53B 1.83B Sep/2026
Gulf Medical Proj AED 450.52M 19.3M Mar/2026
Humana USD 39.61B 477M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Laboratory Of America USD 3.97B 151.3M Sep/2026
Max Healthcare Institute Limited 20.96B 1.51B Sep/2026
Maximus USD 1.64B 132.51M Jun/2026
McKesson USD 66.68B 3.85B Sep/2026
Med Life RON 742.58M 47.12M Mar/2026
Molina Healthcare USD 12.51B 414M Sep/2026
Omnicell USD 783.98M 48.6M Sep/2026
Oriola-kd EUR 483.8M 23.6M Sep/2026
Owens Minor USD 273.92M 2.47M Sep/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Rede D'or Sao Luiz BRL 57.31B 20.66M Sep/2026
Siemens Healthineers EUR 15.65B 694M Sep/2026
Sonova Holding CHF 1.91B 466.3M Jun/2025
Supermax Corporation Bhd MYR 1.18B 191.34M Jun/2026
UnitedHealth USD 85.6B 1.27B Sep/2026
Veeva Systems USD 7.95B 117.03M Jun/2026
Veradigm USD 679.65M 131.12M Dec/2022
Xerox USD 3.64B 59M Sep/2026